VVA
Vida Ventures Advisors Portfolio holdings
AUM
$15.9M
This Quarter Return
+2.33%
1 Year Return
+52.49%
3 Year Return
+45.65%
5 Year Return
-49.37%
10 Year Return
–
AUM
$180M
AUM Growth
+$180M
(+114%)
Cap. Flow
+$49.2M
Cap. Flow
% of AUM
27.31%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
1
Closed
3
Top Buys
| 1 |
Kyverna Therapeutics
KYTX
|
$112M |
Top Sells
| 1 |
Dyne Therapeutics
DYN
|
$47.3M |
| 2 |
LIAN
LianBio American Depositary Shares
LIAN
|
$10.2M |
| 3 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
$5.23M |
| 4 |
IMA
ImageneBio, Inc. Common Stock
IMA
|
$444K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Kyverna Therapeutics
KYTX
$160M
| $112M | 62.43% |
+4,523,924
| New | +$112M |
|
|
CNTA
2
Centessa Pharmaceuticals
CNTA
$2.25B
| $44.4M | 24.68% |
3,931,818
| – | – |
|
|
3
Dyne Therapeutics
DYN
$1.92B
| $11.6M | 6.43% |
407,499
-1,667,288
| -80% | -$47.3M |
|
4
Allogene Therapeutics
ALLO
$251M
| $8.04M | 4.47% |
1,798,163
| – | – |
|
|
KRON
5
DELISTED
Kronos Bio
KRON
| $3.59M | 2% |
2,765,314
| – | – |
|
|
IMA
6
ImageneBio, Inc. Common Stock
IMA
$150M
| – | – |
-225,192
| Closed | -$444K |
|
|
KNTE
7
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| – | – |
-2,207,772
| Closed | -$5.23M |
|
|
LIAN
8
DELISTED
LianBio American Depositary Shares
LIAN
| – | – |
-2,282,084
| Closed | -$10.2M |
|